Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes

British Journal of Pharmacology

Volumn 131, Issue 3, 2000, Pages 645-650

  Gifford, A N ^a   Bruneus, M ^a   Gatley, S J ^a   Volkow, N D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Acetylcholine; Cannabinoid receptors; Cortex; Hippocampus; Synaptosomes

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACETYLCHOLINE; CALCIUM; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; OMEGA CONOTOXIN; POTASSIUM; PRESYNAPTIC RECEPTOR; RIMONABANT; TETRODOTOXIN; TRITIUM;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; ELECTROSTIMULATION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033771946     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703599     Document Type: Article

References (26)

1. Modulation of the Ca+ +-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists
2. Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release
3. Alpha-2 adrenergic inhibition of Ca(+ +)-evoked [3H]norepinephrine release from synaptosomes is blocked by depolarization
4. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process
5. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
6. Electrically-evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR-141716A
7. Large receptor reserve for cannabinoid actions in the central nervous system
8. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)
9. Examination of the effect of the cannabinoid receptor agonist, CP-55,940, on neurotransmitter release from brain slices
10. Effect of the cannabinoid receptor SPECT agent. AM 281, on hippocampal acetylcholine release from rat brain slices
11. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: A double-label in situ hybridization study
12. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
13. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells
14. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells
15. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata
16. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors
17. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system
18. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity
19. Do presynaptic autoreceptors control dopamine release?
20. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
21. Cannabinoid receptor agonists inhibit glutaminergic synaptic transmission in rat hippocampal cultures
22. Mechanisms of cannabinoid-receptormediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons
23. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
24. Neurobiochemical evidence for calcium-induced depolarization of EGTA-pretreated hippocampal synaptosomes
25. Absence of receptor reserve at hippocampal muscarinic autoreceptors which inhibit stimulus-dependent acetylcholine release
26. Pharmacological heterogeneity among calcium channels that subserve acetylcholine release in vertebrate forebrain